ProstateCancerUpdate.net
Home: PCU 5|2004: CME Information

Prostate Cancer Update
A CME Audio Series and Activity

STATEMENT OF NEED / TARGET AUDIENCE

Prostate cancer is one of the most rapidly evolving fields in urologic oncology. Published results from clinical trials lead to the emergence of new surgical and radiation therapy techniques and therapeutic agents, and changes in the indications for existing treatments. In order to offer optimal patient care — including the option of clinical trial participation — the practicing urologist and radiation oncologist must be well informed of these advances. To bridge the gap between research and practice, Prostate Cancer Update utilizes one-on-one discussions with leading urologic oncology and radiation oncology investigators. By providing access to the latest research developments and expert perspectives, this CME program assists urologists and radiation oncologists in the formulation of up-to-date clinical management strategies.

GLOBAL LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to:

  • Critically evaluate the clinical implications of emerging clinical trial data in prostate cancer screening, prevention and treatment.
  • Inform prostate cancer patients about the specific risks and benefits of local and systemic therapies.
  • Offer patients information regarding their prognosis with and without various therapeutic options.
  • Provide individualized counseling to patients regarding the choice and timing of endocrine therapy.
  • Discuss chemotherapy and biologic therapy options in the treatment of prostate cancer.

PURPOSE OF THIS ISSUE OF PROSTATE CANCER UPDATE

The purpose of Issue 5 of Prostate Cancer Update is to support these global objectives by offering the perspectives of clinicians with prostate cancer or those with immediate family members with prostate cancer on these issues.

SPONSORSHIP STATEMENT

Sponsored by Research To Practice.

ACCREDITATION STATEMENT

Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Research To Practice designates this educational activity for a maximum of 3.25 category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

HOW TO USE THIS MONOGRAPH

This CME activity contains both audio and print components. To receive credit, the participant should listen to the CDs or tapes, review the monograph and complete the post-test and evaluation form located in the back of this monograph or on our website. This monograph contains edited comments, clinical trial schemas, graphics and references that supplement the audio program. ProstateCancerUpdate.net includes an easy-to-use interactive version of this monograph with links to relevant full-text articles, abstracts, trial information and other web resources indicated here in red underlined text.

 
   

Home

Editor’s Note:
Visiting professors

The initial reaction to the diagnosis of prostate cancer
Discussing treatment options for localized disease
Treatment side effects and complications
Case discussion: Maximal androgen blockade and radiation therapy for PSA relapse
Psychosocial issues in prostate cancer
Case discussion: PSA progression after intolerable side effects from chemical castration
Case discussion: Androgen deprivation for metastatic
Case discussion: Open versus laparoscopic prostatectomy
Case discussion: In search of a radiation oncologist
Watchful waiting for low-risk disease
Complementary medicine and supportive care
Select publications

CME Information

Faculty Disclosures

Editor’s Office

 
Terms of use and general disclaimer
© Research To Practice, 2004. All rights reserved.